Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

27.11
-0.4300-1.56%
Volume:704.93K
Turnover:19.13M
Market Cap:882.58M
PE:21.35
High:27.68
Open:27.68
Low:26.96
Close:27.54
52wk High:50.79
52wk Low:25.47
Shares:32.56M
Float Shares:31.37M
Volume Ratio:0.94
T/O Rate:2.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.83
PE(LYR):15.67

Loading ...

Collegium Pharmaceutical to buy Corium Therapeutics’ AZSTARYS for USD 650 million

Reuters
·
Mar 19

Collegium Pharmaceutical Inc - Acquisition to Be Funded by Cash on Hand and $300 Mln Term Loan

THOMSON REUTERS
·
Mar 19

Collegium Pharmaceutical Inc - Azstarys Expected to Generate Over $50 Mln in H2 2026 Pro Forma Net Revenue

THOMSON REUTERS
·
Mar 19

Collegium Pharmaceutical Inc - Deal Expected to Be Immediately Accretive to Adj Ebitda

THOMSON REUTERS
·
Mar 19

Collegium to Acquire Azstarys® From Corium Therapeutics, Strengthening Position in Adhd and Accelerating Growth Trajectory

THOMSON REUTERS
·
Mar 19

Collegium Pharmaceutical (COLL) Gets a Buy from Barclays

TIPRANKS
·
Mar 19

Collegium EVP and General Counsel David Dieter Disposes of Common Shares

Reuters
·
Mar 12

Assessing Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Mar 10

Stock Track | Collegium Pharmaceutical Plummets 6.15% Intraday Following Executive Share Disposal

Stock Track
·
Mar 06

Collegium EVP and Chief Commercial Officer Scott Dreyer Disposes of Common Shares

Reuters
·
Mar 06

Collegium Pharmaceutical to Present Real-World Pain Medication Data at PainConnect 2026

Reuters
·
Mar 05

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

TIPRANKS
·
Mar 03

Collegium Pharmaceutical to Present at Barclays 28th Annual Global Healthcare Conference

Reuters
·
Mar 02

A Look At Collegium Pharmaceutical (COLL) Valuation After Mixed Q4 2025 Results And Updated 2026 Guidance

Simply Wall St.
·
Mar 01

Truist Financial Remains a Buy on Collegium Pharmaceutical (COLL)

TIPRANKS
·
Feb 27

Collegium Pharmaceutical Earnings Call: Jornay Leads Growth

TIPRANKS
·
Feb 27

Collegium Pharmaceutical Is Maintained at Buy by Needham

Dow Jones
·
Feb 27

Stock Track | Collegium Pharmaceutical Plummets 8.74% Intraday on Q4 Earnings and Revenue Misses

Stock Track
·
Feb 26

Collegium Pharmaceutical Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Collegium Pharma Q4 Jornay PM net revenue jumps 57% to USD 45.9 million

Reuters
·
Feb 26